The combination of enfortumab vedotin-ejfv plus pembrolizumab represents a chemotherapy-free regimen that could alter the standard of care in the frontline treatment of all patients with metastatic urothelial carcinoma.
We have Dark Horse Comics June 2022 solicits and solicitations in full, from Hellboy to Cyberpunk 77, from new graphic novels like Always Never, to old